Exfoliative dermatitis associated with diltiazem

Journal of Toxicology - Clinical Toxicology

Volumn 35, Issue 1, 1997, Pages 101-104

  Odeh, Majed ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b NONE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; PREDNISONE; PROMETHAZINE;

AGED; ANGINA PECTORIS; ARTICLE; CASE REPORT; EXFOLIATIVE DERMATITIS; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; SYMPTOMATOLOGY;

ANGINA; POMACANTHUS MACULOSUS;

EID: 0031055928     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659709001174     Document Type: Article

References (19)

1. McEvay GK, ed. American Hospital Formulary Service. Drug Information. American Society of Hospital Pharmacists: Bethesda, 1987:727-729.
2. Stern R, Khalsa JH. Cutaneous adverse reactions associated with calcium channel blockers. Arch Intern Med 1989;149:829-832.
3. Hashimoto M, Tanaka S, Horio T. Photosensitivity due to diltiazem hydrochloride. Acta Dermatol 1979;74:181-186.
4. Lavrijsen AP, Van Dijke CV, Vermeer BJ. Diltiazem-associated exfoliative dermatitis in a patient with psoriasis. Acta Derm Venereol 1986;66:536-538.
5. Sanders CJ, Neumann HA. Erythema multiforme, Stevens-Johnson syndrome, and diltiazem. Lancet 1993;341:967.
6. Taylor JW, Cleary JD, Atkinson RC. Stevens-Johnson syndrome associated with diltiazem. Clin Pharm 1990;9:948-950.
7. Carmichael AJ, Paul CJ. Vasculitic leg ulcers associated with diltiazem. BMJ 1988;297:562.
8. Sheehan-Dare RA, Goodfield MJD. Widespread cutaneous vasculitis associated with diltiazem. Postgrad Med J 1988;64:467-468.
9. Hood AF. Cutaneous manifestations of drug reactions. In: Internal Medicine, 2nd ed. Daly WJ, Easton JD, Hutton JJ, et al., eds., Boston/Toronto: Little, Brown and Company Inc., 1987:1384-1391.
10. Reynolds NJ, Jones SK, Crossley J, Harman RR. Exfoliative dermatitis due to nifedipine. Br J Dermatol 1989;121:401-404.
11. Mohammed KN. Nifedipine-induced exfoliative dermatitis and pedal edema. Ann Pharmacother 1994;28:967.
12. Kitamura K, Kanasashi M, Suga C, Saito S, Yoshida S, Ikezawa Z. Cutaneous reactions induced by calcium channel blocker: high frequency of psoriasiformeruptions. J Dermatol 1993;20:279-286.
13. Gonski PN. Stevens-Johnson syndrome induced by verapamil. Med J Aust 1992;156:672.
14. Lin AY, Baker BA. Verapamil-associated Stevens-Johnson syndrome. DICP 1989;23:987-988.
15. Wittal RA, Fischer GO, Georgouras KE, Baird PJ. Skin reactions to diltiazem. Australas J Dermatol 1992;33:11-18.
16. Kuo M, Winiarski N, Garella S. Nonthrombocytopenic purpura associated sequentially with nifedipine and diltiazem. Ann Pharmacother 1992;26:1089-1090.
17. Sheehan-Dare RA, Goodfield MJ. Severe cutaneous vasculitis induced by diltiazem. Br J Dermatol 1988;119:134.
18. del-Rio-Fernandez MC, Plagaro-Coredero ME, de-Frutos-Arribas JF, del-Pozo-Roman T, Martin-Escudero JC. [Leukocytoclastic vasculitis in relation to amlodipine administration.] Rev din Esp 1995;195:738-739.
19. Freedberg IM. Cutaneous Medicine. In: The Principles and Practice of Medicine, 12th ed. Harvey AM, Johns RJ, McKusick VA, Owens AH, Ross RS, eds., New York: Prentice-Hall, Inc., 1980:1473-1494.